Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Plantain leaf extract reduces liver oxidative stress in malaria-infected mice.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Type I interferons play a key role in the development of various skin diseases.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Thuja orientalis hot water extract may help hair grow by starting the growth phase and improving hair follicle development.

Topical finasteride is an effective and safer treatment for male hair loss.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.